Xu C, Wang Y, Hong Y, Yao R, et al. Identification of genetic and immune signatures for the recurrence of HER2-positive breast cancer after trastuzumab-based treatment. Breast Cancer Res Treat 2023 Apr 21. doi: 10.1007/s10549-023-06931.
PMID: 37084155